Table 1.

Current COVID-19 treatment for patients undergoing dialysis.

Type	Antiviral Drug				Immunity Suppressants/Regulators			Neutralizing Antibody
Name	Remdesivir	Molnupiravir	Nirmatrelvir/ Ritonavir	Ensitrelvir	Dexamethasone	Baricitinib	Tocilizumab	Sotrovimab	Casirivimab–imdevimab
Severity to be administered	Mild, Moderate Severe	Mild, Moderate	Mild, Moderate	Mild, Moderate	Moderate, Severe	Moderate, Severe	Moderate, Severe	Mild	Mild
Response to Omicron	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No
Route of administration	Intravenous	Oral	Oral	Oral	Intravenous, oral	Oral	Intravenous	Intravenous	Intravenous
Length of treatment	3–10 days	5 days	5 days	5 days	10 days	14 days	Single dose	Single dose	Single dose
Dosage in dialysis patients	100 mg 4 h before dialysis initiation. Approximately 6 doses	No adjustment required	No administration to dialysis patients	No clinical trials have been conducted in patients with renal dysfunction	No adjustment required	No administration to dialysis patients	No adjustment required	No adjustment required	No adjustment required